← Every company
Genprex Inc Patents
What Genprex Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.
GNPX on carbonthat →Filings on file
9
Granted
0
Still pending
9
Filed under
2 names
9 filings
Newest filing first. A pending application has no patent number yet, and most never get one.
| Invention | Patent |
|---|---|
| METHODS AND COMPOSITIONS FOR TREATING MESOTHELIOMAFiled as GENPREX, INC.2025-09-04MARK S. BERGER | pending |
| METHODS AND COMPOSITIONS FOR TREATING GLIOBLASTOMAFiled as GENPREX, INC.2025-09-03MARK S. BERGER | pending |
| TREATMENT OF CANCER USING COMBINED TUSC2/TUSC4 GENE THERAPYFiled as Genprex, Inc.2025-07-18Mark S. Berger | pending |
| MAINTENANCE THERAPY FOR TREATING CANCERFiled as GENPREX, INC.2025-03-31MARK S. BERGER | pending |
| METHODS OF TREATING PET POSITIVE CANCERSFiled as GENPREX, INC.2025-02-07MARK S. BERGER | pending |
| TREATMENT OF ALK POSITIVE CANCERSFiled as GENPREX, INC.2025-02-06MARK S. BERGER | pending |
| Vectors for Increasing NPRL2 Expression in Cancer Cells and Methods of Use ThereofC07K 14/4703, A61P 35/00, A61K 38/1709, A61K 48/005, A61K 48/0066, C12N 15/85, C12N2830/42, C12N2830/50Filed as Genprex, Inc.2024-05-15Michael Redman | pending |
| TREATMENT OF CANCER USING COMBINED TUSC2/TUSC4 GENE THERAPYFiled as GENPREX, INC.2024-02-12MARK S. BERGER | pending |
| Methods of Treating PET Positive CancersFiled as Genprex, Inc.2024-02-07Mark S. Berger | pending |
Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.